Brief Report
Copyright ©The Author(s) 1996.
World J Gastroenterol. Sep 15, 1996; 2(3): 185-186
Published online Sep 15, 1996. doi: 10.3748/wjg.v2.i3.185
Table 1 Comparison serum alpha-fetoprotein, carbohydrate antibody19-9 and carcinoembryonic antigen in patients with hepatic solid space occupying lesions (x-± s)
GroupingnAFP (μg/L)CA19-9 (KU/L)CEA (μg/L)
1 BHSSOL3011.07 ± 4.3028.43 ± 15.7610.49 ± 6.93
2 SHC3015.23 ± 13.13231.20 ± 196.6427.08 ± 13.35
3 PNHCC3014.03 ± 8.13169.67 ± 140.0819.27 ± 8.67
4 PHCC30320.65 ± 180.1223.73 ± 12.9110.73 ± 3.94
Table 2 Serum alpha-fetoprotein and carbohydrate antibody19-9 + carcinoembryonic antigen in patients with hepatic solid space occupying lesions
GroupingNo. of casesAFP
CA19-9 + CEA
PositiveNegativePositiveNegative
BHSSOL30030030
SHC30327300
PNHCC30
Biliary cell cancer29029290
Mixed cancer11010
PNCC30300030